Hydrochloric Acid → (1R*,2S*)-5'-Methoxy-2-(3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one dihydrochloride
Reaction equation
[ClH:1].[CH3:2][O:3][C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[NH:9][C:8](=[O:13])[C@:7]12[CH2:15][C@H:14]1[C:16]1[CH:24]=[C:23]2[C:19]([C:20]([C:25]3[CH:26]=[N:27][C:28]([N:31]4[CH2:36][CH2:35][N:34]([CH3:37])[CH2:33][CH2:32]4)=[CH:29][CH:30]=3)=[N:21][NH:22]2)=[CH:18][CH:17]=1>CO.C(Cl)Cl>[ClH:1].[ClH:1].[CH3:2][O:3][C:4]1[CH:5]=[C:6]2[C:10](=[CH:11][CH:12]=1)[NH:9][C:8](=[O:13])[C@:7]12[CH2:15][C@H:14]1[C:16]1[CH:24]=[C:23]2[C:19]([C:20]([C:25]3[CH:26]=[N:27][C:28]([N:31]4[CH2:32][CH2:33][N:34]([CH3:37])[CH2:35][CH2:36]4)=[CH:29][CH:30]=3)=[N:21][NH:22]2)=[CH:18][CH:17]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
HCl (4M in dioxane, 0.20 mL, 0.80 mmol) was added in a dropwise manner to a solution of (1R*,2S*)-5′-methoxy-2-(3-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indazol-6-yl)spiro[cyclopropane-1,3′-indolin]-2′-one (92 mg, 0.19 mmol) in MeOH (1 mL) and DCM (4 mL). The mixture was stirred for 1 h at rt prior to evaporation of the solvent in vacuo. MeOH (5 mL) and EtOAc (3 mL) were added, and filtration yielded the title compound as a beige solid (92.7 mg, 88%). 1H NMR (400 MHz, d6-DMSO) δ ppm 13.24 (br. s, 1H), 10.78 (br. s, 1H), 10.46 (s, 1H), 8.72 (s, 1H), 8.22 (dd, J=9.2, 2.0 Hz, 1H), 7.92 (d, J=8.0 Hz, 1H), 7.52 (s, 1H), 7.15 (d, J=8.8 Hz, 1H), 7.03 (d, J=8.4 Hz, 1H), 6.74 (d, J=8.4 Hz, 1H), 6.57 (dd, J=8.4, 2.4 Hz, 1H), 5.71 (d, J=2.4 Hz, 1H), 4.48 (d, J=14 Hz, 2H), 3.50 (d, J=11.6 Hz, 2H), 3.33 (t, J=12.8 Hz, 2H), 3.29 (s, 3H), 3.20 (t, J=8.4 Hz, 1H), 3.09 (m, 2H), 2.80 (d, J=4.4 Hz, 3H), 2.35 (m, 1H), 1.99 (m, 1H).
Workup
- customto evaporation of the solvent in vacuo
- additionMeOH (5 mL) and EtOAc (3 mL) were added
- filtrationfiltration
Sources & evidence
- ORD record
- ord-9ce1f68a143f4bd2afcac4f6b39c9585
- Source dataset
- uspto-grants-2013_07
- Patent number
- US08481533B2
Reaction notes
Loading…